Evaluation of the routine hepatitis B immunization programme in Palestine, 1996

Area of Science:

• Immunology
• Public Health
• Pediatrics

Background:

• Hepatitis B poses a significant global health threat, particularly in regions with limited resources.
• Routine childhood immunization is a cornerstone of hepatitis B prevention strategies worldwide.
• Evaluating the efficacy of immunization programs is crucial for public health policy.

Purpose of the Study:

• To assess the effectiveness of the routine hepatitis B vaccination program in Palestine.
• To determine protective antibody levels in immunized versus non-immunized children.
• To identify factors influencing vaccine response, such as age and sex.

Main Methods:

• Analysis of blood samples from 119 children (89 immunized, 30 non-immunized).
• Quantification of hepatitis B antibody levels.
• Comparison of antibody titers between different demographic groups.

Main Results:

• Immunized children exhibited significantly higher protective antibody levels than non-immunized children.
• Antibody levels were lower in immunized children older than 36 months.
• No significant sex-based differences in antibody levels were observed.
• The hepatitis B immunization program showed an 85% preventive impact against transmission.
• The non-responder rate was 14.6%, which is higher than reported in other studies.

Conclusions:

• Routine hepatitis B immunization in Palestine is highly effective in preventing transmission.
• The observed non-responder rate warrants further investigation and potential program adjustments.
• Age may influence long-term antibody persistence, suggesting possible needs for booster doses in older children.